Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06318390 · ClinicalTrials.gov registry record · NA
The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health
A NA study, sponsored by The University of Texas at Arlington.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT06318390 is a NA study that has completed, run by The University of Texas at Arlington. The registered enrollment target is 6 participants.
The verdict
NCT06318390, a NA study, has completed, sponsored by The University of Texas at Arlington.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The primary objectives of this application are to 1) investigate the effect of increased daily consumption of the Keto5 XOGenius beverage on outcomes associated with elevated risk for various neurocognitive and pathophysiological conditions/diseases. And 2) to investigate the effect of daily consumption of the Keto5 XOGenius beverage on the following variables: waist circumference, body weight, and body mass index (BMI).
Interventions
- DIETARY_SUPPLEMENT XO Genius
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06318390
The ClinicalTrials.gov registry entry for NCT06318390 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas at Arlington, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which XO Genius is the first listed.
NCT06318390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06318390 about?
NCT06318390 is a clinical study titled "The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health". The primary objectives of this application are to 1) investigate the effect of increased daily consumption of the Keto5 XOGenius beverage on outcomes associated with elevated risk for various neurocognitive and pathophysiological conditions/diseases. And 2) to investigate the effect of daily consump...
What is the current status of trial NCT06318390?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2023-08-01. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT06318390?
The interventions under investigation include: XO Genius (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06318390?
This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.